Director Shareholding
December 05 2001 - 12:24PM
UK Regulatory
RNS Number:2514O
Cambridge Antibody Tech Group PLC
5 December 2001
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1) Name of company
Cambridge Antibody Technology
2) Name of director
Kevin Johnson
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a non-beneficial
interest or in the case of an individual holder if it is a holding of that
person's spouse or children under the age of 18 or in respect of a
non-beneficial interest
As in 2 above
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
As in 2 Above
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary:
Grant of options under company CSOP scheme.
7) Number of shares/amount of
stock acquired
8) Percentage of issued class
9) Number of shares/amount
of stock disposed
10) Percentage of issued class
11) Class of security
Ordinary 10p shares
12) Price per share
13) Date of transaction
14) Date company informed
15) Total holding following this notification
16) Total percentage holding of issued class following this notification
If a director has been granted options by the company please complete the
following boxes
17) Date of grant
4 December 2001
18) Period during which or date on which exercisable
4 December 2004 - 3 December 2011
19) Total amount paid (if any) for grant of the option
Nil
20) Description of shares or debentures involved: class, number
Ordinary 10p shares - 13,260 shares
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
1704p
22) Total number of shares or debentures over which options held
following this notification
111,603
23) Any additional information
24) Name of contact and telephone number for queries
Diane Mellett 01763 263233
25) Name and signature of authorised Company official responsible for
making this notification
Diane Mellett Company Secretary
Date of Notification 5 December 2001
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1) Name of company
Cambridge Antibody Technology
2) Name of director
John Aston
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a non-beneficial
interest or in the case of an individual holder if it is a holding of that
person's spouse or children under the age of 18 or in respect of a
non-beneficial interest
As in 2 above
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
As in 2 Above
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
Grant of options under Company CSOP scheme.
7) Number of shares/amount of
stock acquired
8) Percentage of issued class
9) Number of shares/amount
of stock disposed
10) Percentage of issued class
11) Class of security
12) Price per share
13) Date of transaction
14) Date company informed
15) Total holding following this notification
16) Total percentage holding of issued class following this notification
If a director has been granted options by the company please complete the
following boxes
17) Date of grant
4 December 2001
18) Period during which or date on which exercisable
4 December 2004 - 3 December 2011
19) Total amount paid (if any) for grant of the option
Nil
20) Description of shares or debentures involved: class, number
Ordinary 10p shares - 13,489 shares
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
1704p
22) Total number of shares or debentures over which options held
following this notification
202,472
23) Any additional information
24) Name of contact and telephone number for queries
Diane Mellett 01763 263233
25) Name and signature of authorised company official responsible for
making this notification
Diane Mellett Company Secretary
Date of Notification 5 December 2001
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1) Name of company
Cambridge Antibody Technology
2) Name of director
David Glover
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a non-beneficial
interest or in the case of an individual holder if it is a holding of that
person's spouse or children under the age of 18 or in respect of a
non-beneficial interest
As in 2 above
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
As in 2 Above
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
Grant of options under Company CSOP scheme.
7) Number of shares/amount of
stock acquired
8) Percentage of issued class
9) Number of shares/amount
of stock disposed
10) Percentage of issued class
11) Class of security
12) Price per share
13) Date of transaction
14) Date company informed
15) Total holding following this notification
16) Total percentage holding of issued class following this notification
If a director has been granted options by the company please complete the
following boxes
17) Date of grant
4 December 2001
18) Period during which or date on which exercisable
4 December 2004 - 3 December 2011
19) Total amount paid (if any) for grant of the option
Nil
20) Description of shares or debentures involved: class, number
Ordinary 10p shares - 13,260 shares
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
1704p
22) Total number of shares or debentures over which options held
following this notification
113,243
23) Any additional information
24) Name of contact and telephone number for queries
Diane Mellett 01763 263233
25) Name and signature of authorised company official responsible for
making this notification
Diane Mellett Company Secretary
Date of Notification 5 December 2001
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1) Name of company
Cambridge Antibody Technology
2) Name of director
David Chiswell
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a non-beneficial
interest or in the case of an individual holder if it is a holding of that
person's spouse or children under the age of 18 or in respect of a
non-beneficial interest
As in 2 above
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
As in 2 Above
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
Grant of options under Company CSOP scheme.
7) Number of shares/amount of
stock acquired
8) Percentage of issued class
9) Number of shares/amount
of stock disposed
10) Percentage of issued class
11) Class of security
12) Price per share
13) Date of transaction
14) Date company informed
15) Total holding following this notification
16) Total percentage holding of issued class following this notification
If a director has been granted options by the company please complete the
following boxes
17) Date of grant
4 December 2001
18) Period during which or date on which exercisable
4 December 2004 - 3 December 2011
19) Total amount paid (if any) for grant of the option
Nil
20) Description of shares or debentures involved: class, number
Ordinary 10p shares - 259,934
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
1704p
22) Total number of shares or debentures over which options held
following this notification
259,934
23) Any additional information
24) Name of contact and telephone number for queries
Diane Mellett 01763 263233
25) Name and signature of authorised company official responsible for
making this notification
Diane Mellett Company Secretary
Date of Notification 5 December 2001
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jul 2023 to Jul 2024
